Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
about
Adefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infectionUpdate on human herpesvirus 6 biology, clinical features, and therapyAntiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapyAdvancements in Pharmacotherapy for Noncancerous Manifestations of HPVSynthesis of nucleoside phosphate and phosphonate prodrugsCurrent and potential treatments for ubiquitous but neglected herpesvirus infectionsMechanism of Activation of -D-2'-Deoxy-2'-Fluoro-2'-C-Methylcytidine and Inhibition of Hepatitis C Virus NS5B RNA PolymeraseSynthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine PhosphoribosyltransferasesApproved Antiviral Drugs over the Past 50 YearsHow I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipientsTenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trialEnrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, ThailandThe antiviral drug valacyclovir successfully suppresses salivary gland hypertrophy virus (SGHV) in laboratory colonies of Glossina pallidipesAntiviral drug resistance of human cytomegalovirus.High prevalence of respiratory viral infections in patients hospitalized in an intensive care unit for acute respiratory infections as detected by nucleic acid-based assaysComparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitroVaricella-zoster virus infections in immunocompromised patients - a single centre 6-years analysisIdentification of adenovirus, influenza virus, parainfluenza virus, and respiratory syncytial virus by two kinds of multiplex polymerase chain reaction (PCR) and a shell vial culture in pediatric patients with viral pneumonia.Tsetse salivary gland hypertrophy virus: hope or hindrance for tsetse control?Nephrotoxicity related to new therapeutic compounds.Acyclic nucleoside phosphonates: a key class of antiviral drugs.Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs.Synthesis and antiviral activity of 7-deazaneplanocin A against orthopoxviruses (vaccinia and cowpox virus).KSHV/HHV8-associated lymphomas.Folding properties of cytosine monophosphate kinase from E. coli indicate stabilization through an additional insert in the NMP binding domainSynthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action.Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1.Antivirals and antiviral strategies.First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses.Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection.Emerging therapies for herpes viral infections (types 1 - 8).Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis.A survey of antiviral drugs for bioweapons.The Oncogenic Small Tumor Antigen of Merkel Cell Polyomavirus Is an Iron-Sulfur Cluster Protein That Enhances Viral DNA ReplicationGlycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeuticsSusceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.A 65-Year-Old Female from Connecticut with Orf InfectionOrthopoxvirus targets for the development of new antiviral agents.
P2860
Q24187530-225FE9B2-82C6-4B80-BC40-D1757EDAE63FQ24557543-B0BE87E0-7BF0-44F6-A1F7-AEC033DE1F9FQ24672068-2262BBC5-DB57-434D-9030-B1526E6103E4Q26799538-64684283-963E-4B82-9B78-85FB296A960BQ26865400-A18D4549-51C5-4441-8CAB-A09E0CC70082Q27023452-160A40A4-247F-4323-AD0C-91DA266D00B0Q27478073-27DFBC81-6FBF-4571-B744-AF77F516C33CQ27702146-8F591C64-D4A1-4C2C-A0BC-DD6DA9E48757Q27755387-7DC5658F-5744-4BEC-A061-6FCCFDC4B7A4Q28069489-F2302ED6-F33F-422C-A542-AB3EC072F49EQ28469218-9B57B737-4530-4838-8C04-0A1720D0761AQ28477258-9ACCFEBB-7D67-4790-AB73-66D6B42C5FC3Q28484103-839D02CC-3DB7-4DDD-A355-25B0F80BA84BQ30430427-1853E46E-97F1-4487-9EA2-D576C2489438Q33592272-C270183A-62A5-4736-A79C-AD3BEB8CA45BQ33804593-C0023B17-D222-4F28-B9E4-48ECAC9F7007Q33898322-28CCD936-2BE8-4513-816D-F4C8E5CE62CFQ34015110-659F36E1-5C8C-4B16-82B2-51ACF372A7DEQ34017981-6A92344C-E9E7-4E3B-9D20-802DD482C0BDQ34426673-624D0D11-D079-4C10-ABA5-62C6C924D330Q34464655-EAC1A9A0-D1FE-4007-BE4B-C4E9155655D2Q34571871-9B62F763-94CB-4E6C-B0F0-1B39A23DE118Q34684802-6E3961F8-DFAB-4A83-99CA-01796AF9A5DCQ34711929-5E624681-5E26-4F3B-8B59-66AA82738D6BQ35036395-97932711-1355-4554-8E21-4F1017745168Q35046606-EAF6BB7F-EE76-4A7D-BFAE-0CDF09B06DC8Q35185934-A7E90784-DB2C-4F51-8A18-4962568DD6D3Q35499525-76B310DB-85DE-4D3B-A962-294049BE61F7Q35889586-AEF521D1-1A3B-4B4E-94C6-1B33D2342C7EQ35941261-F39B0CAE-3F20-449A-9506-DE7EE13D13C2Q35964751-6C9E0F44-5D39-480F-A80D-8E2338BF2A28Q35967376-E4F369E2-87EE-4616-BDD8-02A87E585DA4Q36097686-3E3CE332-DF31-4A46-831B-D1F4459F7C73Q36203140-9FEC971B-1364-40B7-A0F1-C090A3A55C1EQ36295162-44355107-1E6A-41C1-B70D-8FAAFE5ADA3BQ36481522-88831AB2-C091-43EE-B91F-F342BEFD95A5Q36866689-041ED17A-137C-426F-B603-FD8ECDD76E5BQ36917438-6CCD9DD0-3E8E-43BD-B67C-3AF4A4904E5CQ37096319-73581382-E3A2-4C5D-A655-99C1693E44BDQ37173398-4A3F45D3-1E7E-4679-BBC4-0E3B845DB69A
P2860
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Clinical potential of the acyc ...... rus and retrovirus infections.
@ast
Clinical potential of the acyc ...... rus and retrovirus infections.
@en
type
label
Clinical potential of the acyc ...... rus and retrovirus infections.
@ast
Clinical potential of the acyc ...... rus and retrovirus infections.
@en
prefLabel
Clinical potential of the acyc ...... rus and retrovirus infections.
@ast
Clinical potential of the acyc ...... rus and retrovirus infections.
@en
P2860
P1476
Clinical potential of the acyc ...... rus and retrovirus infections.
@en
P2860
P304
P356
10.1128/CMR.16.4.569-596.2003
P407
P577
2003-10-01T00:00:00Z